ICON Public Limited (NASDAQ:ICLR) Receives Average Rating of “Moderate Buy” from Analysts

ICON Public Limited (NASDAQ:ICLR) has been given an average rating of “Moderate Buy” by the fifteen analysts that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $287.00.

A number of equities analysts have recently commented on ICLR shares. Citigroup dropped their target price on ICON Public from $300.00 to $290.00 and set a “buy” rating for the company in a report on Monday, January 6th. Redburn Atlantic initiated coverage on shares of ICON Public in a research report on Monday, October 14th. They set a “neutral” rating and a $311.00 price objective on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $263.00 target price on shares of ICON Public in a research note on Wednesday, January 15th. TD Cowen cut their price target on shares of ICON Public from $369.00 to $285.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Finally, Robert W. Baird decreased their price objective on shares of ICON Public from $249.00 to $225.00 and set a “neutral” rating for the company in a research note on Wednesday, November 20th.

Institutional Investors Weigh In On ICON Public

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ICLR. Park Place Capital Corp grew its holdings in ICON Public by 281.4% in the fourth quarter. Park Place Capital Corp now owns 225 shares of the medical research company’s stock valued at $47,000 after purchasing an additional 166 shares during the period. GAMMA Investing LLC grew its stake in ICON Public by 64.0% in the 4th quarter. GAMMA Investing LLC now owns 433 shares of the medical research company’s stock valued at $91,000 after acquiring an additional 169 shares during the period. Whittier Trust Co. of Nevada Inc. increased its holdings in ICON Public by 23.1% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 511 shares of the medical research company’s stock worth $147,000 after acquiring an additional 96 shares in the last quarter. First Horizon Advisors Inc. raised its position in ICON Public by 33.9% during the third quarter. First Horizon Advisors Inc. now owns 597 shares of the medical research company’s stock worth $172,000 after acquiring an additional 151 shares during the period. Finally, Avior Wealth Management LLC lifted its holdings in ICON Public by 76.0% during the fourth quarter. Avior Wealth Management LLC now owns 894 shares of the medical research company’s stock valued at $187,000 after purchasing an additional 386 shares in the last quarter. 95.61% of the stock is owned by institutional investors and hedge funds.

ICON Public Price Performance

ICLR stock opened at $200.48 on Monday. ICON Public has a 52 week low of $183.38 and a 52 week high of $347.72. The firm has a market capitalization of $16.54 billion, a P/E ratio of 22.35, a price-to-earnings-growth ratio of 1.52 and a beta of 1.20. The company has a fifty day simple moving average of $209.54 and a two-hundred day simple moving average of $263.28. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 0.35.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.